BY JOHN DOYLE: For healthy children, the highs and lows of everyday life can be challenging enough. But for kids with Type 1 diabetes, the terms “high” and “low” can mean something much more serious.
Calvin Day, a Somersworth 7-year-old with Type 1 Diabetes, wears a continuous glucose monitor around the clock to track his blood-sugar levels. But recently he obtained a new tool to help him monitor blood sugar a diabetic alert dog, a 10-month-old Aussiedoodle named King.
“He’s going to have to bond with me by following me around,” said Day, a second grader at Maple Wood School. “He knows that I have diabetes and knows if I’m low or high. High means I’m wicked out of control. Low means I’m tired.” (read more)
BY JEREMY YOUNG: Today, International Women’s Day, while we celebrate the achievements of women around the globe and call for gender equality, let us also take the opportunity to put a spotlight on health issues that affect women.
We recognize that good health is fundamental to enabling women to live a full life and one of the health risks that women, and the broader community in Asia, are lacking awareness of is gestational diabetes, which affects one in seven births, according to the International Diabetes Foundation. (read more)
BY MARLENE BUSKO: In a snapshot cross-sectional analysis of study participants with type 1 diabetes in Finland, drinking three or more cups of filtered coffee a day was associated with increased odds of having metabolic syndrome, in contrast to previous findings in the general population.
The article, by B Stutz of the University of Helsinki, Finland, and colleagues, based on data from the Finnish Diabetic Nephropathy (FinnDiane) study, was published online February 1 in Nutrition, Metabolism & Cardiovascular Diseases.
“In contrast to the previous observations in other populations, coffee consumption was associated with higher odds of [metabolic syndrome] in the current study” in people with type 1 diabetes, the researchers report. (read more)
BY GEN NEWS: Researchers in Sweden and the U.S. report new insights into how the human body sets its target blood glucose level—the glycemic set point—and say their findings could have implications for ongoing diabetes research and the development of regenerative therapies.
Every animal species has its own signature glycemic set point, and a normal glucose level for one species may be life threatening to another. What hasn’t been known until now, however, is which organ is responsible for defining that glycemic set point in each species. Karolinska Institutet researchers, led by Per-Olof Berggren, Ph.D., have now shown that transplanting the islets from different species into mice resulted in the recipient animals taking on the glycemic set point of the donor species. “We found that the engrafted islets transferred the glycemic levels of the donor species,” comments Dr. Berggren, a researcher at the department of molecular medicine and surgery’s Rolf Luft Research Centre for Diabetes and Endocrinology. “This indicates that the pancreatic islets have the overall responsibility for maintaining normal blood glucose levels, making them the ‘glucostat’ in our bodies.” (read more)
BY PAM HARRISON: Being younger when diagnosed with type 2 diabetes is associated with an increased risk of all-cause and cardiovascular disease (CVD) mortality compared with being diagnosed at a later stage in life, a large Australian cohort study has shown.
“Evidence is accumulating to suggest that earlier onset of type 2 diabetes is associated with an increased risk of complications and comorbidities compared with later onset, and that the development and progression of complications might be more aggressive in those with earlier onset,” say the authors, led by Lili Huo, MD, of the Baker Heart and Diabetes Institute in Melbourne, Australia.
“Early and aggressive risk factor management is warranted for individuals with young-onset type 2 diabetes,” they conclude. (read more)